12/03/2026by adminFor the 3 year in a row we are the best 12/03/2026by adminBasel SGA 2026 12/03/2026by adminArab Health 2025 31/07/2024by adminMeet our AI- driven robot 09/01/2024by ElixiPlease join us in congratulating Fabio for his first successful year in Elixi! 13/09/2023by ElixiCome and meet us at Expopharm 2023! 27 -30 September in DÜSSELDORF. 08/09/2023by ElixiSeptember is the World Alzheimer’s awareness Month 2023 04/07/2023by ElixiElixi International is proud to announce the opening of our subsidiary in Singapore! 29/06/2023by ElixiFDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes 25/06/2023by ElixiA new class of medicines to treat pediatric type 2 diabetes 10/06/2023by ElixiWe join in celebrating Global Wellness Day! 05/06/2023by ElixiTargeted Therapy Vorasidenib Offers Hope for Deadly Brain Tumors 30/05/2023by ElixiMay is World Bladder Cancer Awareness Month. 23/05/2023by ElixiWorld Thyroid day, 25th May 2023 17/05/2023by ElixiElixi is officially a Great Place to Work in Switzerland 2023!! 02/05/2023by ElixiFirst vaccine to protect older adults from respiratory syncytial virus (RSV) infection 20/04/2023by ElixiWorld Orphan Drug Congress 2023 10/03/2023by ElixiElixi will be at the 27th EAHP (The European Association of Hospital Pharmacists) Annual Congress, from the 22nd to the 24th of March 2023 in Lisbon, Portugal. 07/03/2023by ElixiNew hope for the treatment of neurodegenerative diseases including Lewy bodies dementia and Parkinson’s disease 28/02/2023by ElixiIt’s Rare disease day! 17/02/2023by ElixiWelcome to our new Export Manager, Federica! 03/02/2023by ElixiFind Elixi at Arab Health! 16/01/2023by ElixiFabio Macchi is our new Head of Medical and Quality Departments. 30/03/2022by ElixiCarvykti (ciltacabtagene autoleucel), new gene therapy to treat adult patients with multiple myeloma 11/03/2022by ElixiJardiance (empagliflozin)approved for Wider Range of Patients with Heart Failure 09/03/2022by ElixiKimmtrak (tebentafusp), a monotherapy for the treatment of adult patients with uveal melanoma, a rare type of eye cancer. 07/02/2022by ElixiBreyanzi (lisocabtagene maraleucel) New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma 03/11/2021by ElixiCyltezo(adalimumab-adbm), the First Interchangeable Biosimilar to Humira
